TOFIDENCE — Total Revenue
Biogen TOFIDENCE — Total Revenue decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $100.00K to $0.00. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful market penetration, growing physician adoption, or effective commercial execution for the product, while a decrease may signal increased competition, loss of market share, or product lifecycle maturity.
Detailed definition
This metric represents the total gross sales generated from the commercialization of the Tofidence product line. It refl...
Peer comparison
Comparable to product-specific revenue lines reported by other biopharmaceutical companies for individual branded therapies or biosimilars.
biib_segment_tofidence_total_revenueHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $800.00K | $200.00K | $100.00K | $100.00K | $0.00 | $0.00 | $600.00K | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | -75.0% | -50.0% | +0.0% | -100.0% | — | — | -100.0% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | -100.0% | -100.0% | +500.0% | -100.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's tofidence — total revenue?
- Biogen (BIIB) reported tofidence — total revenue of $0.00 in Q1 2026.
- How has Biogen's tofidence — total revenue changed year-over-year?
- Biogen's tofidence — total revenue decreased by 100.0% year-over-year, from $100.00K to $0.00.
- What does tofidence — total revenue mean?
- The total amount of money earned from sales of the Tofidence product.